Back to search
FDAFDA · Food and drugs·Recall number D-0174-2023

Clobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-956-03

Published February 1, 2023 · Recall initiated: January 20, 2023

Summary

FDA records drug Class III recall D-0174-2023, published February 1, 2023 and initiated January 20, 2023. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 5720 tubes; Lot: Lot#: K101033; Exp 6/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Low assay result observed during long-term stability testing.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if CLOBETASOL PROPIONATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CLOBETASOL PROPIONATE
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
USA Nationwide
Lot
Lot#: K101033; Exp 6/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-956-03 recalled?

Yes. FDA published recall D-0174-2023 on February 1, 2023. Reported hazard: Subpotent Drug: Low assay result observed during long-term stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CLOBETASOL PROPIONATE.